Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrients ; 14(14)2022 Jul 13.
Article in English | MEDLINE | ID: mdl-35889825

ABSTRACT

The impact of selenium on the course of Hashimoto's thyroiditis (HT) was mainly assessed by monitoring the titer of antithyroid autoantibodies in most of the studies conducted hitherto. On the other hand, the imbalance in activity of T cells such as Th1, Th2, Th17, and Treg may be relevant in the pathogenesis of this disease. Hence, the assessment of changes in the secretion of cytokines by these cells during selenium supplementation in patients with HT seems to be an important issue and was the main goal of this study. A further aim was to search for correlations among these cytokines, as well as markers of thyroid function, selenium/iodine status in the body, and other biochemical parameters. The group of 29 women with newly diagnosed Hashimoto's thyroiditis was supplemented with selenium in a dose of 100 µg/day for 6 months. Immunological parameters: interferon γ, tumor necrosis factor α, chemokine CXCL10, interleukin 4, interleukin 1ß, interleukin 17, transforming growth factor ß, and C-reactive protein, as well as selenium status parameters were determined in serum twice, i.e., before and after supplementation. Selenium supplementation was associated with a change in the production of two cytokines: interferon γ and interleukin 1ß, for which a decrease and an increase in concentration were observed, respectively. The partial least squares (PLS) model revealed the presence of many relevant correlations among analyzed parameters. The stage of HT development, degree of thyroid dysfunction, and selenium supplementation of diet are interdependent factors which shape the profile of some cytokines secreted by cells participating in the autoimmunity process.


Subject(s)
Hashimoto Disease , Selenium , Cytokines , Dietary Supplements , Female , Humans , Interferon-gamma , Interleukin-1beta
2.
Int J Clin Pract ; 75(9): e14484, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34107151

ABSTRACT

OBJECTIVE: Autoimmune thyroid diseases, including Hashimoto's thyroiditis, are the most common ones among autoimmune diseases. The reported effects of selenium supplementation on the course of Hashimoto's thyroiditis are not consistent. It is therefore important to continue this line of research. DESIGN: The participants received selenium in the form of sodium selenite(IV) at a dose of 100 µg/day for 6 months. PATIENTS: Newly diagnosed and previously untreated Hashimoto's thyroiditis with euthyroidism or subclinical hypothyroidism. A total of 36 patients (aged 20 to 52 years) qualified for this study, of whom 29 women were successfully enrolled and completed the intervention. MEASUREMENTS: Both before and after supplementation the following parameters in serum were tested: anti-thyroid peroxidase antibodies, thyroid function indicators, selenium as well as antioxidant status parameters and other biochemical parameters (lipid profile, glucose). Iodine supply and subjective assessment of physical and psychological health were also monitored. RESULTS: Selenium supplementation decreased significantly level of anti-thyroid peroxidase antibodies what might have had a stabilizing effect on thyroid function, as values of thyroid parameters were within normal range before and at the end of the study. Mean level of selenium among patients was not different to healthy people in Poland. Median of ioduria was within normal range. CONCLUSIONS: The study shows a potential way of protective effect of selenium in limiting development of overt hypothyroidism. The increase in the concentrations of Se and SELENOP in the serum of patients verifies successful supplementation and good compliance, but did not affect the antioxidant status parameters measured.


Subject(s)
Hashimoto Disease , Hypothyroidism , Selenium , Dietary Supplements , Female , Hashimoto Disease/drug therapy , Humans , Hypothyroidism/drug therapy
3.
J Radioanal Nucl Chem ; 318(1): 723-726, 2018.
Article in English | MEDLINE | ID: mdl-30369690

ABSTRACT

It is well known that monitoring of radioactivity released from nuclear medicine departments is necessary to ensure the radiological safety of patients and personnel. Unfortunately, equipment for air sampling is often expensive, loud and is not suitable to use in hospitals. Our goal was to find cheap and simple system for passive monitoring of 131I activity concentration in the air of nuclear medicine departments. Medical activated charcoal tablets were used, because charcoal is excellent material for 131I trapping and tablets are readily available. Our proposed sampling protocol contains tablets preparation, exposure and measurements using HPGe detector. Different methods of tablets preparation (drying, impregnation with KI or NaOH) were tested while an experimental chamber was prepared for estimating 131I (released from Na131I, similar to that used in therapy) trapping efficiency of tablets in different conditions. Finally, tablets were placed in plastic holders and tested in nuclear medicine facilities.

4.
J Radioanal Nucl Chem ; 310(2): 661-670, 2016.
Article in English | MEDLINE | ID: mdl-27746517

ABSTRACT

The paper summarizes results of investigation of the current state of radioactive contamination on site being under consideration for planned nuclear power plant in northern Poland. Thanks to use of sequential procedure it was possible to determine activity concentrations for radioisotopes of nine elements, both natural and artificial. Results show that observed levels of radioactive contamination are rather typical for central Europe and global fallout is dominant factor of presence of artificial radionuclides. The total deposition for artificial radionuclides revealed maxima equal to 1747 ± 121 Bq/m2 for 137Cs, 3854 ± 158 Bq/m2 for 90Sr, 101 ± 23 mBq/m2 for 237Np, 57.7 ± 6.0 Bq/m2 for 241Am, 3.27 ± 0.80 Bq/m2 for 238Pu and 68.5 ± 5.0 Bq/m2 for 239+240Pu.

5.
Biomaterials ; 24(3): 427-33, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12423597

ABSTRACT

Pure beta emitters are the sources of choice for intracoronary irradiations in restenosis prevention. In this work we reconsidered preparation of low activity 32P sources by ion-implantation of stable 31P into highly biocompatible pure titanium stents, followed by neutron activation. Gamma-spectrometrical analysis has shown that during activations with high thermal neutrons flux production of gamma-active long-lived contaminants is much beyond the dosimetrically acceptable limit, mainly due to the competing (n,p) reactions induced by the fast neutrons on isotopes of the bulk stent material, and to a lesser extent due to (n,gamma) reactions on chemical impurities. A potential applicability of this method for obtaining alternative beta radioactive stents is discussed.


Subject(s)
Brachytherapy/instrumentation , Coronary Disease/prevention & control , Coronary Disease/therapy , Neutrons , Stents , Brachytherapy/methods , Chromium Radioisotopes , Gamma Rays , Ions , Phosphorus Radioisotopes , Spectrophotometry , Titanium
SELECTION OF CITATIONS
SEARCH DETAIL
...